Verrica Pharmaceuticals Inc. Earnings Per Share, Basic and Diluted
Verrica Pharmaceuticals Inc. (VRCA) reported Earnings Per Share, Basic and Diluted of -$0.31 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-09
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.31.
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.47.
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.43.
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.04.
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.30.
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.71.
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.13.
- Verrica Pharmaceuticals Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.41.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.31 10-Q · filed 2022-05-09 | ||||||
| 2021-12-31 | -$1.30 10-K · filed 2022-03-02 | ||||||
| 2021-09-30 | -$0.47 10-Q · filed 2021-11-12 | -$0.95 10-Q · filed 2021-11-12 | |||||
| 2021-06-30 | -$0.43 10-Q · filed 2021-08-10 | -$0.46 10-Q · filed 2021-08-10 | |||||
| 2021-03-31 | -$0.04 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | -$1.71 10-K · filed 2022-03-02 | ||||||
| 2020-09-30 | -$0.42 10-Q · filed 2021-11-12 | -$1.19 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$0.38 10-Q · filed 2021-08-10 | -$0.77 10-Q · filed 2021-08-10 | |||||
| 2020-03-31 | -$0.39 10-Q · filed 2021-05-07 | ||||||
| 2019-12-31 | -$0.31 10-K · filed 2020-03-13 | -$1.13 10-K · filed 2021-03-17 | |||||
| 2019-09-30 | -$0.24 10-Q · filed 2020-11-09 | -$0.83 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | -$0.28 10-Q · filed 2020-08-05 | -$0.58 10-Q · filed 2020-08-05 | |||||
| 2019-03-31 | -$0.30 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | -$0.30 10-K · filed 2020-03-13 | -$1.41 10-K · filed 2020-03-13 | |||||
| 2018-09-30 | -$0.24 10-K · filed 2020-03-13 | -$0.27 10-Q · filed 2018-11-07 | -$1.16 10-Q · filed 2019-11-06 | -$1.30 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | -$0.92 10-K · filed 2020-03-13 | -$1.04 10-Q · filed 2018-08-07 | -$1.66 10-Q · filed 2019-08-07 | -$1.82 10-Q · filed 2018-08-07 | |||
| 2018-03-31 | -$0.65 10-K · filed 2020-03-13 | ||||||
| 2017-12-31 | -$0.50 10-K · filed 2019-03-07 | -$1.56 10-K · filed 2019-03-07 | |||||
| 2017-09-30 | -$0.48 10-K · filed 2019-03-07 | -$1.06 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$0.38 10-K · filed 2019-03-07 | -$0.58 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | -$0.20 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |